Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


How Orphan Drugs Became a Highly Profitable Industry

External Link - Source: The Scientist

Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

This entry was posted in Institutions, Centers, Funding and tagged , , . Bookmark the permalink.